Chengdu Kaijie Biopharm Co., Ltd - China

Welcome to

Chengdu Kaijie Biopharm Co., Ltd

Free Member

Chengdu Kaijie Biopharm Co., Ltd
China

Home
Company Info
Contact Us
Share your thoughts
Language
- English

Company Profile

Company Contact

Name:

Ms. Anne Zhou [Sales]

E-mail:

Send Message

Homepage:

www.kjpep.com

Instant Messaging:

Mobile Number:

Phone Number:

Address:

chengdu
611330, Sichuan
China

Average User Review

There is no review for this company - Write a review

Registration Date:

May. 24, 2023

Last Updated:

Mar. 3, 2011

Business Nature:

Manufacturing of Chemicals category

Want to contact this company?

Send Message

Your inquiry will be recorded in "Member Trade Mail".

Put on Company Partner

Recommend to your friends

Company Brief

Chengdu Kaijie Biopharm Co. Ltd. ( KJBP) is one of the leading peptide manufacturers in China. It was founded in Chengdu in March, 2003 by a team of experienced peptide chemists with a combined industrial experience over 20 years.

KJBP has oriented its business along two main lines: the investigation, development, production and commercialization of generic bulk peptide APIs for the international markets, and custom synthesis service for buliding blocks, amino acid resin and peptide sequences which meet researchersâ € ™ specific demand worldwide.

Dayi campus in the suburb of Chengdu city provides KJBP with a good infrastructure for both industrial-scale production of peptides and Custom Synthesis.The pharmaceutical grade solid phase peptide synthesis in Dayi campus can meet USP, EP or the requirements of CP, single batches are up to Kg scales.

KJBP has begun to implement the 2008 development plan which is improving quality management standards and increasing production scale.Currently Chinese GMP is accomplished and the US FDA preparatory work is also under way as scheduled.

Our Mission
To combine innovation with excellence by developing and manufacturing quality peptide accompanied by professional and friendly scientific support.

I am familiar with this company and want to review it.

You have [3] new inquiries.